13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Page 8 of 9 – SEC Filing

Exhibit A

AGREEMENT

The undersigned agree that
this Schedule 13D/A, Amendment No. 6, dated March 15, 2018, relating to the Common Stock par value $0.01 of Recro Pharma, Inc.
shall be filed on behalf of the undersigned.

March 15, 2018
(Date)
BROADFIN CAPITAL, LLC
By:  /s/ Kevin Kotler
Kevin Kotler, Managing Member
KEVIN KOTLER
/s/ Kevin Kotler
BROADFIN HEALTHCARE MASTER FUND, LTD.
By:  /s/ Kevin Kotler
Kevin Kotler, Director

Follow Societal Cdmo Inc. (NASDAQ:SCTL)